Search - tctmd.com

Displaying 441 - 460 of 555

Sort: Relevancy | Date

News Industry News

Micell Technologies Announces Clinical Data from MiStent SES Studies Will Be Presented at EuroPCR 2014

May 15, 2014

News Industry News

CRF will Provide Updates on Several Key Cardiovascular Trials at EuroPCR

May 13, 2014

Presentation CIT 2014

Single Center Experience with the first 381 Absorb Implantations

Presenter: Christoph K. Naber

March 20, 2014

Presentation CIT 2014

Absorb Extend: Clinical Program up date

Presenter: Alexandre Abizaid

March 20, 2014

News Industry News

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

March 10, 2014

News Daily News

Un Stent Bioabsorbible de 1ª Generación Funciona Bien en Lesiones de la AFS

Jason Kahn

February 20, 2014

News Daily News

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Jason Kahn

February 20, 2014

News Daily News

Bioresorbable Scaffold Performs Well in Select STEMI Patients

January 22, 2014

News Daily News

Bioresorbable Scaffold Designed for PAD Yields Good Early Results

January 22, 2014

News Daily News

Andamio Bioabsorbible Funciona Bien en Pacientes STEMI Seleccionados

January 22, 2014

News Daily News

Andamio Bioabsorbible Diseñado para el Manejo de la EAP Da Buenos Resultados Preliminares

January 22, 2014

News Daily News

Los Andamiajes Bioabsorbibles resultan Prometedores en Pacientes STEMI Seleccionados

Yael L. Maxwell

January 09, 2014

News Daily News

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Yael L. Maxwell

January 09, 2014

Presentation

Detection and Treatment of Vulnerable Plaque: PROSPECT II and PROSPECT ABSORB

Presenter: Gregg W. Stone

December 02, 2013

Presentation

Absorb Bioresorbable Vascular Scaffold System - (NEW) ABCs of Bioabsorbable Polymeric Scaffolds

Presenter: Richard J. Rapoza

December 02, 2013

Presentation TCT 2013

Rationale for Bioresorbable Vascular Scaffolds as a VP Shield: The PROSPECT ABSORB Trial

Presenter: Gregg Stone

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

Bifurcation Strategies with the Absorb BVS Everolimus-Eluting Resorbable Scaffold: A Bench Study

Presenter: JM White

October 29, 2013

Presentation TCT 2013

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Presenter: Takashi Muramatsu

October 29, 2013

Presentation TCT 2013

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

Presenter: Yoshinobu Onuma

October 29, 2013

Advertisement

Micell Technologies Announces Clinical Data from MiStent SES Studies Will Be Presented at EuroPCR 2014

CRF will Provide Updates on Several Key Cardiovascular Trials at EuroPCR

Single Center Experience with the first 381 Absorb Implantations

Absorb Extend: Clinical Program up date

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

Un Stent Bioabsorbible de 1ª Generación Funciona Bien en Lesiones de la AFS

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Bioresorbable Scaffold Performs Well in Select STEMI Patients

Bioresorbable Scaffold Designed for PAD Yields Good Early Results

Andamio Bioabsorbible Funciona Bien en Pacientes STEMI Seleccionados

Andamio Bioabsorbible Diseñado para el Manejo de la EAP Da Buenos Resultados Preliminares

Los Andamiajes Bioabsorbibles resultan Prometedores en Pacientes STEMI Seleccionados

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Detection and Treatment of Vulnerable Plaque: PROSPECT II and PROSPECT ABSORB

Absorb Bioresorbable Vascular Scaffold System - (NEW) ABCs of Bioabsorbable Polymeric Scaffolds

Rationale for Bioresorbable Vascular Scaffolds as a VP Shield: The PROSPECT ABSORB Trial

Innovation in Intervention: Perspectives from Industry

Bifurcation Strategies with the Absorb BVS Everolimus-Eluting Resorbable Scaffold: A Bench Study

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content